BioMed Research International

BioMed Research International / 2011 / Article
Special Issue

Protein Acetylation and the Physiological Role of HDACs

View this Special Issue

Review Article | Open Access

Volume 2011 |Article ID 129383 |

Tomohiro Hayakawa, Jun-ichi Nakayama, "Physiological Roles of Class I HDAC Complex and Histone Demethylase", BioMed Research International, vol. 2011, Article ID 129383, 10 pages, 2011.

Physiological Roles of Class I HDAC Complex and Histone Demethylase

Academic Editor: Minoru Yoshida
Received15 Jul 2010
Accepted07 Sep 2010
Published26 Oct 2010


Epigenetic gene silencing is one of the fundamental mechanisms for ensuring proper gene expression patterns during cellular differentiation and development. Histone deacetylases (HDACs) are evolutionally conserved enzymes that remove acetyl modifications from histones and play a central role in epigenetic gene silencing. In cells, HDAC forms a multiprotein complex (HDAC complex) in which the associated proteins are believed to help HDAC carry out its cellular functions. Though each HDAC complex contains distinct components, the presence of isoforms for some of the components expands the variety of complexes and the diversity of their cellular roles. Recent studies have also revealed a functional link between HDAC complexes and specific histone demethylases. In this paper, we summarize the distinct and cooperative roles of four class I HDAC complexes, Sin3, NuRD, CoREST, and NCoR/SMRT, with respect to their component diversity and their relationship with specific histone demethylases.

1. Introduction

Eukaryotic chromosomes consist of two cytologically defined structures, euchromatin, and heterochromatin. Euchromatin contains transcribable genes, which are subject to either activation or inactivation depending on the cellular situation, whereas heterochromatin contains transcriptionally inert genes. Structural changes in chromatin are tightly linked with posttranscriptional modifications of the histone tails. The combinations of histone modifications establish local and global patterns of chromatin structure and define specific downstream events [1]. These patterns are highly dynamic and can be altered by multiple extracellular and intracellular stimuli. Thus, chromatin has been proposed to serve as a signaling platform by which various signaling pathways are integrated.

Among the numerous covalent modifications identified so far, acetylation and methylation play central roles in chromatin dynamics [2]. Histone acetylation on lysine residues is primarily associated with gene activation, and its levels are controlled by two counteracting enzymes: histone acetyltransferases (HATs) and histone deacetylases (HDACs). Many lysine and arginine residues on histones are target sites of methylation. In contrast to acetylation, histone methylation is linked with both gene activation and inactivation and is regulated by histone methyltransferases (HMTs) and histone demethylases (HDMs). In most cases, these histone-modifying enzymes are present in multisubunit protein complexes, in which the other components are thought to regulate enzyme activities, modulate substrate recognition, recruit other cofactors, or carry out other undefined functions.

In metazoans, HDACs are divided into three classes, Class I to Class III, based on their sequence similarity. Class I HDACs, which include HDAC1, HDAC2, and HDAC3, are found in four distinct multiprotein complexes, the Sin3, NuRD, CoREST, and NCoR/SMRT complexes. These complexes are highly conserved and function in distinct cellular processes including cell-cycle regulation [3, 4], maintenance of stem cell pluripotency [5], self-renewal, and cellular differentiation. Recent studies have revealed that all of these complexes are associated with specific HDMs. The HDMs are classified into two distinct enzyme families: the nuclear amine oxidase homologs and the JmjC-domain proteins. LSD1 (KDM1A, also known as AOF2/BHC110) is a member of the former family and was the first histone lysine demethylase identified; it preferentially demethylates methylated histone H3 lysine 4 (H3K4me) [6]. The latter enzyme family, the JmjC-domain proteins, plays important roles in development and cellular differentiation [710]. This family has 27 members in mammals, and these members are divided into 11 subgroups based on similarity within the JmjC domain [11]. So far, seven of these subgroups have been shown to have demethylase activity for specific residues on histone H3 or H4.

To achieve strict transcriptional regulation in the complicated chromosomal architecture of the nucleus, it makes sense that eukaryotic organisms developed a system involving combinatorial histone modifications and protein complexes that contain multiple enzymatic activities, such as HDAC and HDM. It is noteworthy that cells produce a variety of HDAC-containing complexes by replacing an integral component with one of its subtypes. These subtype-specific HDAC complexes appear to play distinct roles in particular cellular contexts. In addition, incorporating sequence-specific DNA-binding proteins, such as zinc-finger proteins, can also modulate the function of the HDAC complex. In this paper, we focus on how HDAC-HDM interactions and subtype-specificity regulate functions of the Class I HDAC-containing complexes, in transcriptional regulation and other cellular processes.

2. The Sin3 Complex

The HDAC-containing multiprotein complex, Sin3 complex, is highly conserved from yeast to humans. In mammalian cells, the Sin3 complex consists of six core subunits, HDAC1/2, RbAp46, RbAp48, Sin3A/Sin3B, SAP18, and SAP30 (Figure 1(a)) [1214]. Mammalian Sin3A and Sin3B (mSin3A and mSin3B) show high sequence similarity and an overlapping expression pattern, and both are essential in mouse development. However, these subtypes play distinct and nonoverlapping roles. mSin3A has a critical role in the early developmental preimplantation stage, since no mSin3A-null zygotes are found at E6.5 [15]. mSin3A-depleted mouse embryonic fibroblasts (MEFs) exhibit the deregulation of genes involved in cell-cycle control, DNA replication, DNA repair, apoptosis, chromatin modification, and mitochondrial metabolism. Transcriptome analysis has revealed that mSin3A modulates the transcriptional network controlled by Myc-Mad, E2F, or p53. On the other hand, mSin3B has an essential function at the late-gestation stage, and its mutant is different from the mSin3A-/- embryo [16]. In particular, erythrocyte and granulocyte differentiation and G0/G1 cell-cycle control are impaired in the mSin3B-/- embryo, and these phenotypes are due to the derepression of E2F target genes.

Transcriptional regulation is tightly coupled with dynamic change of histone acetylation in the promoter regions. However, the Sin3 complex functions not only at promoter regions but also at transcribed regions. In Saccharomyces cerevisiae, Sin3 and a Class I HDAC, Rpd3, are involved with two functionally distinct complexes, Rpd3L and Rpd3S [17]. Both complexes contain Sin3, Rpd3, and Ume1. In addition to these core subunits, Rpd3L contains at least six unique components: Rxt1, Rxt2, Dep1, Sds3, Pho23, and Sap30, whereas Rpd3S contains Rco1 and Eaf3 as unique components (Figure 1(b)) [18]. Rpd3L is localized primarily to promoter regions. In contrast, Rpd3S is localized to transcribed regions that are enriched in methylated H3K36 (H3K36me). H3K36me is a mark catalyzed by Set2 (KMT3) and is tightly coupled with the transcriptional elongation processes [19]. Rpd3S recognizes this H3K36me mark via a combined action of chromodomain of Eaf3 and PHD (plant homeobox domain) of Rco1 [2022]. Deletion of Set2 or one of the Rpd3S-specific components results in spurious transcripts that emerge from incorrect transcription start sites in some transcriptionally active genes [17]. Since the H4 acetylation levels within transcribed regions are increased in these mutant cells, Rpd3S is thought to repress unfavorable transcription by maintaining transcribed regions in a hypoacetylated state. In metazoans, however, the relationship between mSin3 complexes and the emergence of aberrant transcripts remains unclear.

One of the Rpd3S-specific components, Eaf3, is highly conserved from yeast to humans. The human Eaf3 homologue MRG15 was initially identified as a factor closely related to MORF4 (mortality factor on human chromosome 4), whose transient expression induces senescence in a subset of human tumor cell lines [23, 24]. MRG15 is a stable component of mSin3-HDAC complexes, and the MRG15-associated mSin3-HDAC complex also contains Pf1, a component that shares similarity with S. cerevisiae Rco1 [25], and a histone H3K4-specific demethylase, RBP2 (KDM5A) [26] (Figure 1(a)). Of note, MRG15 is shared with at least two other complexes: the Tip60 (NuA4)-HAT complex [2628] and the BRCA2-containing DNA-damage-responsive complexes [29, 30]. Although we will not discuss these complexes further in this paper, the MRG15-associated complexes are implicated in DNA-damage responses [29, 3133], in addition to transcriptional regulation, suggesting that histone acetylation dynamics is tightly coupled with histone eviction/deposition during DNA-repair processes.

We previously demonstrated that MRG15 recruits RBP2 and controls the H3K4me levels on transcribed regions via the RBP2 activity [26]. In addition, van Oevelen et al. reported that the majority of Sin3 target genes (58%) are bound by RBP2, which spreads over the region immediately downstream of the transcription start site on a subset of E2F target genes during differentiation [34]. These results suggest that the Sin3-HDAC complex and RBP2 play a cooperative role in repressing target genes through deacetylation, demethylation, and, probably, the repositioning of nucleosomes. In S. cerevisiae, no evidence has been reported for a physical interaction or functional link between the Sin3 complex and the KDM5 homologue Jhd2. In Drosophila, RPD3, MRG15, and PF1, but not SIN3, were identified in an LID-(a KDM5 homologue) containing complex [35]. Intriguingly, the deacetylation activity of RPD3 is inhibited by its interaction with any of these associated proteins, including LID, implying that the relationship between the HDAC and HDM activities is counteractive.

Recent reports have shown that LID associates with SIN3 and functions in Notch silencing [36]. The Notch signaling pathway plays pleiotropic roles during embryonic development and is important for the regulation of cellular self-renewal [37, 38]. Moshkin et al., purified factors associated with histone chaperones (ASF1 and NAP1) from Drosophila S2 cells or embryonic nuclear extract, and identified several peptides, including LID, SIN3A, PF1, RPD3, MRG15, and a BRCA2-binding protein, EMSY. Using a reciprocal purification approach, they further showed that NAP1 binds the RPD3 and LID-Associated Factors (RLAFs) consisting of RPD3, LID, SIN3A, PF1, EMSY, and MRG15, whereas ASF1 binds LAF, a similar complex lacking RPD3 (Figure 1(c)). Both of these complexes, RLAF-NAP1 (RLAF-N) and LAF-ASF1 (LAF-A), are required for the transcriptional repression of Notch-regulated genes. In agreement with the enzymatic activity of LID, the knockdown of ASF1, NAP1, or any of the LAF components results in an accumulation of H3K4me3 at the promoter and enhancer regions. Interestingly, H3K4me3 accumulation is not observed in RPD3 knockdown cells [36]. This implies that LID recruitment to the promoter/enhancer regions of Notch target genes may not depend on the entire RPD3-containing RLAF complex. Considering that the RPD3-containing RLAF complex resembles Rpd3S in S. cerevisiae in its subunit composition (Figures 1(b) and 1(c)), it is possible that RLAF acts at the rest of transcribed regions, with or without the association with NAP1. This possibility will be tested by future studies.

RBP2/KDM5A was also found to be involved in the Notch pathway in a study using mammalian cells [39]. RBP-J is a nuclear effector of Notch signaling. Upon ligand binding, RBP-J activates the expression of Notch target genes, and, in the absence of Notch signal, RBP-J switches off the target gene expression. Liefke et al. showed that RBP2/KDM5A associates with RBP-J in vivo. RBP2/KDM5A is colocalized with RBP-J at the promoter region of Notch target genes and regulates their expression. Although the involvement of HDAC at the target promoter region was not described in this study, it is most likely that RBP2 works together with an HDAC complex, as in the case of the LAF-A complex in Drosophila.

Another function of the Sin3 complex was revealed by a genome-wide study. The gene-expression profiles of Sin3-depleted Drosophila cells were analyzed by high-density oligonucleotide array [40]. This analysis revealed that the expression of ~3% of the Drosophila genes is altered in Sin3-depleted cells. The affected genes are associated with diverse biological processes, including signal transduction, transcriptional regulation, and cell-cycle control. Interestingly, the list of affected genes also includes a substantial fraction of genes involved in cytosolic and mitochondrial energy-generating pathways. Furthermore, Sin3-deficient Drosophila cells exhibit an increase in mitochondrial mass. In accordance with this observation, the genome-wide analysis of RBP2-binding sites using human breast cancer cell lines revealed that RBP2 is enriched at genes encoding proteins that localize to the mitochondrion, including mitochondrial ribosomal proteins [41]. Moreover, the alteration of RBP2 leads to mitochondrial defects in human cells, as in Sin3-depleted Drosophila cells.

Overall, the Sin3-HDAC complexes associated with KDM5 regulate the transcription of many genes, in processes such as Notch signaling and mitochondrial functions. Notably, the transcriptional regulation is achieved by dynamic changes in histone modifications not only at promoter regions, but also at transcribed regions. The Sin3-KDM5 complex appears to play an important role at both regions by exchanging its associated cofactors.

3. The Mi-2/NuRD Complex

The NuRD complex was first purified based on its histone deacetylase and nucleosome-remodeling activities [14, 42, 43]. Although the NuRD complex has been identified in mammalian and Xenopus cells, its major components have also been found in Drosophila, C. elegans, and Arabidopsis, suggesting that the complex exists widely in animal and plant species. The biochemical association of the histone deacetylase and nucleosome-remodeling activities suggests that these two activities are functionally coupled in this complex action.

The NuRD core complex consists of HDAC1/2, RbAp46, RbAp48, CHD3/CHD4 (Mi-2), MBD2/MBD3, MTA1/MTA2/MTA3, and p66α/p66β (Figure 2(a)). HDAC1/2 and RbAp46/48 are shared with the Sin3 complex. Mi-2 was first identified as an autoantigen in the human connective tissue disease dermatomyositis [44], and is a member of the SWI2/SNF2-related chromatin-remodeling ATPases, which target the chromatin region and unwind the nucleosome structure. MBD2 and MBD3 belong to the MBD (methyl-CpG binding) domain family although MBD3 is unable to bind methyl-CpG [45, 46]. Since the NuRD complex can interact with both MBD2 and MBD3, it was first hypothesized to target methylated DNA through its interaction with MBD2 [47]. However, recent reports have shown that MBD3 and MBD2 are exclusively associated with the NuRD complex and form distinct complexes, MBD3/NuRD and MBD2/NuRD [48]. MBD3 and MBD2 are very similar (70% identical), but only MBD3 is essential for mouse development [49].

The MTA protein family has three members, MTA1, MTA2, and MTA3, and vertebrates have two additional splicing variants, small form of MTA1 (MTA1s) and MTA3L [50, 51]. MTA1s, however, lacks a nuclear localization signal and is found in the cytoplasm [50]; it is therefore unlikely to be a component of nuclear Mi-2/NuRD. Among these MTAs, MTA1 and MTA3 have been clearly shown to be involved in tumor progression. Their expression is upregulated in several types of tumors, and their expression states are closely correlated with the invasive growth properties of tumors [5153]. MTA1 is induced by the growth factor heregulin and is a potent corepressor of estrogen-receptor element-(ERE-)driven transcription [54]. Similarly, in breast epithelial cells, MTA3 is induced by estrogen, constitutes an estrogen-dependent component of the Mi-2/NuRD complex, and plays a critical role in repressing the expression of Snail, a master regulator of the epithelial-to-mesenchymal transition [51]. These data suggest that MTA proteins are mutually exclusive in the NuRD complex (Figure 2(a)) and that distinct NuRD complexes function as transcriptional repressors in different signaling pathways.

The NuRD complex plays important roles in development. Mice lacking a functional Mbd3 gene die prior to midgestation [49]. Embryonic stem (ES) cells lacking Mbd3 are viable, but they fail to completely silence genes that are expressed before implantation of the embryo [55] and are unable to commit to developmental lineages [56]. Another NuRD component, p66, was first cloned in Drosophila as a genetic modifier of the Wingless signaling pathway. The human paralogs p66α (GATAD2A) and p66β (GATAD2B) function synergistically in transcriptional repression, and both bind to MBD2 [57]. Although p66α is not required for normal blastocyst development or implantation, loss-of-function mutant embryos of p66α die at around day 10 of embryogenesis [58].

ES cells require several key molecules, such as Nanog and Oct4, for their self-renewal and pluripotency [59]. Nanog-containing complexes were recently purified from mouse ES cells, and several NuRD-related components were identified as Nanog-interacting proteins [5]. Interestingly, the Nanog-interacting NuRD-like complex contains most of the NuRD components (Mta1, Mta2, Hdac1/2, p66α, and p66β) but lacks Chd3/4, Mbd3, and RbAp46/Rbbp7 (Figure 2(b)). This NuRD-like unique complex was thus named NODE (for Nanog- and Oct4-associated deacetylase). Without Mbd3, deacetylase activity in the canonical NuRD complex is greatly reduced [47], but the NODE complex contains HDAC activity comparable to that of NuRD complexes. Importantly, Mbd3-knockdown ES cells show different gene-expression profiles than Mta1- or Mta2-knockdown ES cells. Moreover, while Mbd3 loss-of-function mutant ES cells can self-renew, the knockdown of NODE subunits leads to the increased expression of developmentally regulated genes and ES-cell differentiation. These observations support the idea that NODE is functionally distinct from canonical NuRD.

Although the functional interaction between NuRD/NODE and histone demethylases in ES cells is still unknown, cooperative roles of NuRD and LSD1 have been described (Figure 2(a)) [60]. Using HeLa cells, Wang et al. purified the MTA2-containing protein complexes and identified LSD1 in addition to other NuRD components [60]. LSD1 interacts directly with all three MTA proteins and appears to form distinct complexes. The NuRD-LSD1 complexes target distinct, yet overlapping, sets of genes. Transcriptional analyses have revealed that these complexes regulate several cellular signaling pathways, including TGFβ, cell-communication, focal-adhesion, MAPK, and cell-cycle pathways, which are critically involved in cell growth, survival, migration, and invasion. Furthermore, LSD1 inhibits the invasion of breast cancer cells in a Mi-2-dependent manner in vitro and suppresses breast cancer metastatic potential in vivo. In fact, LSD1 is downregulated in breast carcinomas and negatively correlated with TGFβ1 expression.

Collectively, the LSD1/NuRD complex is required for the repression of important genes in cellular signaling pathways and suppresses breast cancer metastasis. While LSD1 is a component of NuRD complexes, it has been also observed that LSD1 targets promoter regions independent of NuRD [60]. Therefore, it is likely that LSD1 also functions as a component of currently unidentified protein complexes.

4. The CoREST Complex

CoREST was first identified as a corepressor of REST (RE-1 Silencing Transcription Factor, also known as NRSF) [61] and later demonstrated to be a component of HDAC1/2-containing complexes [62]. The CoREST complex contains HDAC1/2, p80, Sox-like protein, ZNF217 (p110a), and LSD1 (p110b) (Figure 3(a)). Although p110b was identified in the first purification study, its catalytic activity was later identified and renamed LSD1 [6]. Because the CoREST complex does not associate with mSin3, MTA, CHD4, or RbAp46/48, it is thought to be distinct from the other HDAC-containing complexes. The CoREST protein contains two SANT domains, a conserved domain resembling the DNA-binding domains of Myb-related DNA-binding proteins. This domain was originally identified in SWI3, ADA3, NCoR, and TFIIIB (and thus named SANT) [63], and it is also present in the MTA proteins. Interestingly, the demethylase activity of LSD1 to the nucleosomal substrates requires the CoREST protein [64]. In addition, the CoREST/LSD1 complex shows high demethylase activity for a hypoacetylated nucleosome substrate, and the SANT domain of CoREST preferentially interacts with hypoacetylated histone tails, as was also previously observed for the SANT domain of SMRT [65]. These results suggest that the HDACs in the CoREST/LSD1 complex function upstream of LSD1 and that deacetylated states are recognized by CoREST, which facilitates LSD1’s enzymatic activity.

ZNF217, the other CoREST complex component, is a Krüppel-like zinc-finger protein. The ZNF217 complex purified from HeLa cells includes LSD1, CoREST, HDAC2, and CtBP [66]. The zinc-finger motif of ZNF217 specifically binds to the DNA sequence CAGAAY (Y means C or T), and this consensus is highly conserved in the E-cadherin promoter. In fact, ZNF217 and other CoREST complex components are found on the E-cadherin promoter, which is repressed by ZNF217. As ZNF217 overexpression has been noted in many cancer cell lines [66], aberrant protein levels of ZNF217 may cause unregulated targeting by the CoREST-LSD1 complex, with a profound effect on cancer progression.

The transcriptional corepressor CtBP (C-terminal binding protein) is also implicated in tumorigenesis. Immunoaffinity purification of the CtBP complex revealed that it contains all of the CoREST complex components [67]. In this analysis, many other interactors were also identified (G9a, HuHMT, HPC2, REBB-1, and ZNF516) [67]. As described for ZNF217, CtBP and the complex components, EuHMT and G9a, also repress E-cadherin promoter activity. Another report showed that Snail, a master regulator of the epithelial-to-mesenchymal transition, forms a complex with LSD1 and CoREST, and functions to recruit LSD1 activity to the E-cadherin promoter [68]. Together, these results suggest that the CoREST complex is a kind of “core complex” that associates with the CtBP complex as an effector module (Figure 3(a)). Considering that CoREST also associates with other corepressors required for hematopoietic differentiation, Gfi-1 and Gfi1-b [69], it is likely that CoREST forms several distinct complexes depending on the cellular situation.

5. The NCoR/SMRT Complex

Nuclear hormone receptors are evolutionally conserved, ligand-dependent transcription factors that influence the biological processes of cell proliferation and differentiation in metazoans. NCoR (Nuclear receptor CoRepressor, also known as NCOR1) and SMRT (Silencing Mediator for Retinoid and Thyroid receptor, also known as NCOR2) bind to nuclear hormone receptors and act as “platform proteins” in recruiting a large protein complex that includes Class I and II HDAC and mSin3A [70]. Of note, proteins homologous to NCoR or SMRT are not found in the yeast genome, as is the case for the nuclear hormone receptors. These proteins appear to have arisen during the evolution of metazoan organisms to allow unliganded nuclear hormone receptors to repress transcription via the Sin3-HDAC pathway [70]. SMRT and NCoR share a similar domain organization and are thought to be paralogues.

NCoR and SMRT are essential for development, but their mutant phenotypes are quite different. NCoR appears to be critical to neural differentiation and the developmental progression of erythrocytes and thymocytes [71, 72], whereas SMRT is required for heart development [72]. The SMRT and NCoR complexes share interacting partners, including HDAC3, TBL1 (transducin β-like 1), TBLR1 (TBL related 1), and GPS2 (G-protein pathway suppressor 2) (Figure 3(b)) (reviewed in [73]). Moreover, 114 and 98 proteins, respectively, are reported to interact physically with NcoR and SMRT (BioGRID). NCoR and SMRT also associate with other HDAC members, HDAC4, HDAC5, and HDAC7, but these enzymatic activities are dependent on the SMRT/NCoR-HDAC3 complex [74]. Previous studies demonstrated that diverse transcription factors, including Mad/Mxi, BCL6/LAZ3, ETO, RBP-J, and REST/NRSF, interact with the NCoR and SMRT complexes [75, 76].

Several demethylases that interact with NCoR have been identified. KDM4A (former name, JMJD2/JDM3A/JMJD2A/KIAA0677) was identified in an affinity-purified NCoR complex [77]. KDM4A is not a core subunit of the NCoR complex, and it is not required for NCoR-mediated repression by thyroid hormone receptor. However, KDM4A is required for selective repression of the ASCL2 gene, which is an imprinted gene essential for proper placental development, and this repression requires a functional NCoR complex [78]. KDM4A specifically demethylates tri- and dimethylated lysine-9 and lysine-36 of histone H3 (H3K9/36 me3/2) [79]. A recent study showed that KDM4 also demethylates lysine-26 of histone H1.4 (H1.4K26me), which is one of seven somatic H1 isotypes in humans, and is known to cause transcriptional repression [80]. Considering that both H3K9me3/2 and H1.4K26me are repressive histone marks, it is unclear how KDM4’s enzymatic activity is coupled with NCoR-mediated repression. Nevertheless, the substrate specificity of KDM4 may be modulated within N-CoR-containing complexes. Further studies are required to elucidate the function of the KDM4-associated NCoR complex and the resulting histone-modification dynamics.

KDM5C (also known as SMCX/JARID1C) has histone H3K4-specific demethylase activity and functions as a transcriptional repressor. KDM5C is implicated in X-linked mental retardation, epilepsy, and autism [8183]. Tahiliani et al., purified a KDM5C-containing complex from HeLa cells and identified NCoR [84]. This complex also contains HDAC1/2, the H3K9-specific methyltransferase G9a, REST (RE-1 Silencing Transcription factor, also known as NRSF), which represses neuronal genes in non-neuronal tissues, along with other proteins that are primarily involved in transcriptional repression. REST not only maintains the transcriptional silencing of a range of neuronal genes in differentiated non-neuronal cells but also plays key roles during lineage commitment in neurogenesis (reviewed in [85]). Tahiliani et al., further showed that KDM5C functions at a subset of REST-regulated neuronal specific genes [84]. It should be noted that NCoR was previously shown to form a stable complex with HDAC3, TBL1, TBLR1, and GPS2 [73], but these proteins were not identified in the KDM5C-containing complex. Thus, it is not clear how NCoR functions in the KDM5C-REST complex. However, a requirement for NCoR in astroglia differentiation was clearly demonstrated [71]. REST modulates not only neuronal, but also glial lineage elaboration [86]. Therefore, it is possible that a unique NCoR-SMCX-REST complex specifically functions in glial development.

Despite its similarity to the NCoR complex, there is no report showing a direct interaction between the SMRT complex and HDMs. However, SMRT appears to control HDM function in trans. SMRT knockout mice exhibit embryonic lethality, with impaired neural development as well as heart defects [72]. SMRT represses the expression of the gene encoding an H3K27-specific demethylase KDM6B (JMJD3), which is also a direct target of the retinoic acid receptor. Retinoic acid induction leads to the release of SMRT from the KDM6B gene promoter, and then KDM6B derepresses neurogenic genes in neural stem cells. This finding uncovered a novel hierarchical relationship between the activities of SMRT and HDM in maintaining the neural stem-cell state.

6. Conclusion

Many HDACs do not function by themselves but act as a component in a multiprotein complex. This complex formation appears to help each HDAC to exert its catalytic activity more effectively and/or specifically. As described above, most HDAC-containing complexes are associated with histone demethylases (HDMs), and the cooperative action of these enzymatic activities enables the complex to act on multiply modified histones at transcriptionally repressive gene regions. Incorporating subtype components gives rise to variations that allow these complexes to repress a wide variety of target genes. Below, we summarize the points raised in this paper.( )The two mammalian Sin3 complexes have distinct functions. In embryonic development, mSin3A is required during the preimplantation stage, whereas mSin3B is required in late gestation. In particular, mSin3B is essential for erythrocyte and granulocyte differentiation.( )S. cerevisiae has two Sin3-containing complexes, Rpd3L and Rpd3S. Rpd3L is required for transcriptional repression at gene promoter regions, whereas Rpd3S is located at transcribed regions and prevents spurious transcription from incorrect transcription start sites. The Drosophila KDM5 protein LID is associated with the SIN3 complex. The LID-SIN3 complex functions to repress the Notch-signaling pathway. Similarly, the human KDM5A protein, RBP2, is required to repress genes of the Notch-signaling pathway.( )Two types of MBD protein, MBD2 and MBD3, are distinctively involved in the NuRD complex. Mbd3/NuRD, but not Mbd2/NuRD, is essential for mouse development. Another NuRD component, MTA1/MTA2/MTA3, also contributes to produce distinct complexes. NuRD complexes with each MTA protein bind to specific promoter regions. ( )Mouse embryonic stem cells contain a specialized NuRD-related complex, NODE. The stem-cell-specific factors Nanog and Oct4 are associated with the NODE complex, which represses several differentiation marker genes. ( )LSD1 (KDM1A) is associated with the NuRD complex. There are three distinct LSD1-NuRD complexes, LSD1/MTA1/NuRD, LSD1/MTA2/NuRD, and LSD1/MTA3/NuRD. These three different complexes target distinct yet overlapping sets of genes.( )LSD1 is also associated with the CoREST complex. Furthermore, all the CoREST complex components are included in the CtBP-containing complex. Many of these components are required for the repression of the E-cadherin promoter.( )NCoR/SMRT is the transcriptional repression machinery for nuclear-receptor-mediated transcription. NCoR has critical roles in neural differentiation and hematopoiesis, whereas SMRT is required for heart development. KDM4A is associated with the NCoR complex, and its association is required for ASCL2 gene repression. The NCoR complex also binds SMCX (KDM5C), and the NCoR-SMCX-REST complex functions in glial development.

The transcriptional repression machinery is highly elaborate, and we still lack a complete picture of the transcriptional repression mechanisms. Future studies will continue to uncover these complicated mechanisms.


The authors thank their laboratory members at the RIKEN CDB for helpful discussions and S. Seno for excellent secretarial work. This research was supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.


  1. B. D. Strahl and C. D. Allis, “The language of covalent histone modifications,” Nature, vol. 403, no. 6765, pp. 41–45, 2000. View at: Publisher Site | Google Scholar
  2. T. Kouzarides, “Chromatin modifications and their function,” Cell, vol. 128, no. 4, pp. 693–705, 2007. View at: Publisher Site | Google Scholar
  3. J. B. Rayman, Y. Takahashi, and Y. Takahashi, “E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex,” Genes and Development, vol. 16, no. 8, pp. 933–947, 2002. View at: Publisher Site | Google Scholar
  4. E. Balciunaite, A. Spektor, and A. Spektor, “Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells,” Molecular and Cellular Biology, vol. 25, no. 18, pp. 8166–8178, 2005. View at: Publisher Site | Google Scholar
  5. J. Liang, M. Wan, and M. Wan, “Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells,” Nature Cell Biology, vol. 10, no. 6, pp. 731–739, 2008. View at: Publisher Site | Google Scholar
  6. Y. Shi, F. Lan, and F. Lan, “Histone demethylation mediated by the nuclear amine oxidase homolog LSD1,” Cell, vol. 119, no. 7, pp. 941–953, 2004. View at: Publisher Site | Google Scholar
  7. R. J. Klose, Q. Yan, and Q. Yan, “The retinoblastoma binding protein RBP2 is an H3K4 demethylase,” Cell, vol. 128, no. 5, pp. 889–900, 2007. View at: Publisher Site | Google Scholar
  8. P. A. C. Cloos, J. Christensen, and J. Christensen, “The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3,” Nature, vol. 442, no. 7100, pp. 307–311, 2006. View at: Publisher Site | Google Scholar
  9. K. Agger, P. A. C. Cloos, and P. A. C. Cloos, “UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development,” Nature, vol. 449, no. 7163, pp. 731–734, 2007. View at: Publisher Site | Google Scholar
  10. F. Lan, P. E. Bayliss, and P. E. Bayliss, “A histone H3 lysine 27 demethylase regulates animal posterior development,” Nature, vol. 449, no. 7163, pp. 689–694, 2007. View at: Publisher Site | Google Scholar
  11. R. J. Klose and Y. Zhang, “Regulation of histone methylation by demethylimination and demethylation,” Nature Reviews Molecular Cell Biology, vol. 8, no. 4, pp. 307–318, 2007. View at: Publisher Site | Google Scholar
  12. Y. Zhang, R. Iratni, H. Erdjument-Bromage, P. Tempst, and D. Reinberg, “Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex,” Cell, vol. 89, no. 3, pp. 357–364, 1997. View at: Publisher Site | Google Scholar
  13. Y. Zhang, Z.-W. Sun, R. Iratni, H. Erdjument-Bromage, P. Tempst, M. Hampsey, and D. Reinberg, “SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex,” Molecular Cell, vol. 1, no. 7, pp. 1021–1031, 1998. View at: Google Scholar
  14. Y. Zhang, G. LeRoy, H.-P. Seelig, W. S. Lane, and D. Reinberg, “The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities,” Cell, vol. 95, no. 2, pp. 279–289, 1998. View at: Publisher Site | Google Scholar
  15. J.-H. Dannenberg, G. David, S. Zhong, J. Van Der Torre, W. H. Wong, and R. A. DePinho, “mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival,” Genes and Development, vol. 19, no. 13, pp. 1581–1595, 2005. View at: Publisher Site | Google Scholar
  16. G. David, K. B. Grandinetti, P. M. Finnerty, N. Simpson, G. C. Chu, and R. A. DePinho, “Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 11, pp. 4168–4172, 2008. View at: Publisher Site | Google Scholar
  17. M. J. Carrozza, B. Li, and B. Li, “Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription,” Cell, vol. 123, no. 4, pp. 581–592, 2005. View at: Publisher Site | Google Scholar
  18. M.-C. Keogh, S. K. Kurdistani, and S. K. Kurdistani, “Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex,” Cell, vol. 123, no. 4, pp. 593–605, 2005. View at: Publisher Site | Google Scholar
  19. M. L. Youdell, K. O. Kizer, E. Kisseleva-Romanova, S. M. Fuchs, E. Duro, B. D. Strahl, and J. Mellor, “Roles for Ctk1 and Spt6 in regulating the different methylation states of histone H3 lysine 36,” Molecular and Cellular Biology, vol. 28, no. 16, pp. 4915–4926, 2008. View at: Publisher Site | Google Scholar
  20. B. Sun, J. Hong, P. Zhang, X. Dong, X. Shen, D. Lin, and J. Ding, “Molecular basis of the interaction of Saccharomyces cerevisiae Eaf3 chromo domain with methylated H3K36,” Journal of Biological Chemistry, vol. 283, no. 52, pp. 36504–36512, 2008. View at: Publisher Site | Google Scholar
  21. C. Xu, G. Cui, M. V. Botuyan, and G. Mer, “Structural basis for the recognition of methylated histone H3K36 by the Eaf3 subunit of histone deacetylase complex Rpd3S,” Structure, vol. 16, no. 11, pp. 1740–1750, 2008. View at: Publisher Site | Google Scholar
  22. B. Li, M. Gogol, M. Carey, D. Lee, C. Seidel, and J. L. Workman, “Combined action of PHD and chromo domains directs the Rpd3S HDAC to transcribed chromatin,” Science, vol. 316, no. 5827, pp. 1050–1054, 2007. View at: Publisher Site | Google Scholar
  23. M. J. Bertram, N. G. Bérubé, X. H. Swanson, and O. M. Pereira-Smith, “Assembly of a BAC contig of the complementation group B cell senescence gene candidate region at 4q33-q34.1 and identification of expressed sequences,” Genomics, vol. 56, no. 3, pp. 353–354, 1999. View at: Publisher Site | Google Scholar
  24. M. J. Bertram and O. M. Pereira-Smith, “Conservation of the MORF4 related gene family: identification of a new chromo domain subfamily and novel protein motif,” Gene, vol. 266, no. 1-2, pp. 111–121, 2001. View at: Publisher Site | Google Scholar
  25. G. S. Yochum and D. E. Ayer, “Role for the mortality factors MORF4, MRGX, and MRG15 in transcriptional repression via associations with Pf1, mSin3A, and transducin-like enhancer of split,” Molecular and Cellular Biology, vol. 22, no. 22, pp. 7868–7876, 2002. View at: Publisher Site | Google Scholar
  26. T. Hayakawa, Y. Ohtani, N. Hayakawa, K. Shinmyozu, M. Saito, F. Ishikawa, and J.-C. Nakayama, “RBP2 is an MRG15 complex component and down-regulates intragenic histone H3 lysine 4 methylation,” Genes to Cells, vol. 12, no. 6, pp. 811–826, 2007. View at: Publisher Site | Google Scholar
  27. Y. Cai, J. Jin, and J. Jin, “Identification of new subunits of the multiprotein mammalian TRRAP/TIP60-containing histone acetyltransferase complex,” Journal of Biological Chemistry, vol. 278, no. 44, pp. 42733–42736, 2003. View at: Publisher Site | Google Scholar
  28. Y. Doyon, W. Selleck, W. S. Lane, S. Tan, and J. Côté, “Structural and functional conservation of the NuA4 histone acetyltransferase complex from yeast to humans,” Molecular and Cellular Biology, vol. 24, no. 5, pp. 1884–1896, 2004. View at: Publisher Site | Google Scholar
  29. T. Hayakawa, F. Zhang, N. Hayakawa, Y. Ohtani, K. Shinmyozu, J. -I. Nakayama, and P. R. Andreassen, “MRG15 binds directly to PALB2 and stimulates homology-directed repair of chromosomal breaks,” Journal of Cell Science, vol. 123, no. 7, pp. 1124–1130, 2010. View at: Publisher Site | Google Scholar
  30. S. M.-H. Sy, M. S. Y. Huen, and J. Chen, “MRG15 is a novel PALB2-interacting factor involved in homologous recombination,” Journal of Biological Chemistry, vol. 284, no. 32, pp. 21127–21131, 2009. View at: Publisher Site | Google Scholar
  31. J.-I. Nakayama, G. Xiao, and G. Xiao, “Alp13, an MRG family protein, is a component of fission yeast Clr6 histone deacetylase required for genomic integrity,” EMBO Journal, vol. 22, no. 11, pp. 2776–2787, 2003. View at: Publisher Site | Google Scholar
  32. T. Kusch, L. Florens, and L. Florens, “Acetylation by Tip60 is required for selective histone variant exchange at DNA lesions,” Science, vol. 306, no. 5704, pp. 2084–2087, 2004. View at: Publisher Site | Google Scholar
  33. S. N. Garcia, B. M. Kirtane, A. J. Podlutsky, O. M. Pereira-Smith, and K. Tominaga, “Mrg15 null and heterozygous mouse embryonic fibroblasts exhibit DNA-repair defects post exposure to gamma ionizing radiation,” FEBS Letters, vol. 581, no. 27, pp. 5275–5281, 2007. View at: Publisher Site | Google Scholar
  34. C. van Oevelen, J. Wang, P. Asp, Q. Yan, W. G. Kaelin Jr., Y. Kluger, and B. D. Dynlacht, “A role for mammalian Sin3 in permanent gene silencing,” Molecular Cell, vol. 32, no. 3, pp. 359–370, 2008. View at: Publisher Site | Google Scholar
  35. N. Lee, H. Erdjument-Bromage, P. Tempst, R. S. Jones, and Y. Zhang, “The H3K4 demethylase lid associates with and inhibits histone deacetylase Rpd3,” Molecular and Cellular Biology, vol. 29, no. 6, pp. 1401–1410, 2009. View at: Publisher Site | Google Scholar
  36. Y. M. Moshkin, T. W. Kan, and T. W. Kan, “Histone chaperones ASF1 and NAP1 differentially modulate removal of active histone marks by LID-RPD3 complexes during NOTCH silencing,” Molecular Cell, vol. 35, no. 6, pp. 782–793, 2009. View at: Publisher Site | Google Scholar
  37. S. J. Bray, “Notch signalling: a simple pathway becomes complex,” Nature Reviews Molecular Cell Biology, vol. 7, no. 9, pp. 678–689, 2006. View at: Publisher Site | Google Scholar
  38. U. Koch and F. Radtke, “Notch and cancer: a double-edged sword,” Cellular and Molecular Life Sciences, vol. 64, no. 21, pp. 2746–2762, 2007. View at: Publisher Site | Google Scholar
  39. R. Liefke, F. Oswald, and F. Oswald, “Histone demethylase KDM5A is an integral part of the core Notch-RBP-J repressor complex,” Genes and Development, vol. 24, no. 6, pp. 590–601, 2010. View at: Publisher Site | Google Scholar
  40. L. A. Pile, P. T. Spellman, R. J. Katzenberger, and D. A. Wassarman, “The SIN3 deacetylase complex represses genes encoding mitochondrial proteins: implications for the regulation of energy metabolism,” Journal of Biological Chemistry, vol. 278, no. 39, pp. 37840–37848, 2003. View at: Publisher Site | Google Scholar
  41. N. Lopez-Bigas, T. A. Kisiel, and T. A. Kisiel, “Genome-wide analysis of the H3K4 histone demethylase RBP2 reveals a transcriptional program controlling differentiation,” Molecular Cell, vol. 31, no. 4, pp. 520–530, 2008. View at: Publisher Site | Google Scholar
  42. J. K. Tong, C. A. Hassig, G. R. Schnitzler, R. E. Kingston, and S. L. Schreiber, “Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex,” Nature, vol. 395, no. 6705, pp. 917–921, 1998. View at: Publisher Site | Google Scholar
  43. Y. Xue, J. Wong, G. T. Moreno, M. K. Young, J. Côté, and W. Wang, “NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities,” Molecular Cell, vol. 2, no. 6, pp. 851–861, 1998. View at: Google Scholar
  44. Q. Ge, D. S. Nilasena, C. A. O'Brien, M. B. Frank, and I. N. Targoff, “Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen,” Journal of Clinical Investigation, vol. 96, no. 4, pp. 1730–1737, 1995. View at: Google Scholar
  45. M. Saito and F. Ishikawa, “The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2,” Journal of Biological Chemistry, vol. 277, no. 38, pp. 35434–35439, 2002. View at: Publisher Site | Google Scholar
  46. B. Hendrich and A. Bird, “Identification and characterization of a family of mammalian methyl-CpG binding proteins,” Molecular and Cellular Biology, vol. 18, no. 11, pp. 6538–6547, 1998. View at: Google Scholar
  47. Y. Zhang, H.-H. Ng, H. Erdjument-Bromage, P. Tempst, A. Bird, and D. Reinberg, “Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation,” Genes and Development, vol. 13, no. 15, pp. 1924–1935, 1999. View at: Google Scholar
  48. X. Le Guezennec, M. Vermeulen, A. B. Brinkman, W. A. M. Hoeijmakers, A. Cohen, E. Lasonder, and H. G. Stunnenberg, “MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties,” Molecular and Cellular Biology, vol. 26, no. 3, pp. 843–851, 2006. View at: Publisher Site | Google Scholar
  49. B. Hendrich, J. Guy, B. Ramsahoye, V. A. Wilson, and A. Bird, “Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development,” Genes and Development, vol. 15, no. 6, pp. 710–723, 2001. View at: Publisher Site | Google Scholar
  50. R. Kumar, R.-A. Wang, and R.-A. Wang, “A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm,” Nature, vol. 418, no. 6898, pp. 654–657, 2002. View at: Publisher Site | Google Scholar
  51. N. Fujita, D. L. Jaye, M. Kajita, C. Geigerman, C. S. Moreno, and P. A. Wade, “MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer,” Cell, vol. 113, no. 2, pp. 207–219, 2003. View at: Publisher Site | Google Scholar
  52. Y. Toh, E. Oki, and E. Oki, “Overexpression of the MTA1 gene in gastrointestinal carcinomas: correlation with invasion and metastasis,” International Journal of Cancer, vol. 74, no. 4, pp. 459–463, 1997. View at: Publisher Site | Google Scholar
  53. Y. Toh, H. Kuwano, M. Mori, G. L. Nicolson, and K. Sugimachi, “Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas,” British Journal of Cancer, vol. 79, no. 11-12, pp. 1723–1726, 1999. View at: Google Scholar
  54. A. Mazumdar, R.-A. Wang, and R.-A. Wang, “Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor,” Nature Cell Biology, vol. 3, no. 1, pp. 30–37, 2001. View at: Publisher Site | Google Scholar
  55. K. Kaji, I. M. Caballero, R. MacLeod, J. Nichols, V. A. Wilson, and B. Hendrich, “The NuRD component Mbd3 is required for pluripotency of embryonic stem cells,” Nature Cell Biology, vol. 8, no. 3, pp. 285–292, 2006. View at: Publisher Site | Google Scholar
  56. K. Kaji, J. Nichols, B. Hendrich, and B. Hendrich, “Mbd3, a component of the NuRD co-repressor complex, is reqiured for development of pluripotent cells,” Development, vol. 134, no. 6, pp. 1123–1132, 2007. View at: Publisher Site | Google Scholar
  57. M. Brackertz, Z. Gong, J. Leers, and R. Renkawitz, “p66α and p66β of the Mi-2/NuRD complex mediate MBD2 and histone interaction,” Nucleic Acids Research, vol. 34, no. 2, pp. 397–406, 2006. View at: Publisher Site | Google Scholar
  58. S. Marino and R. Nusse, “Mutants in the mouse NuRD/Mi2 component P66alpha are embryonic lethal,” PloS One, vol. 2, no. 6, article e519, 2007. View at: Google Scholar
  59. I. Chambers and A. Smith, “Self-renewal of teratocarcinoma and embryonic stem cells,” Oncogene, vol. 23, no. 43, pp. 7150–7160, 2004. View at: Publisher Site | Google Scholar
  60. Y. Wang, H. Zhang, and H. Zhang, “LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer,” Cell, vol. 138, no. 4, pp. 660–672, 2009. View at: Publisher Site | Google Scholar
  61. M. E. Andres, C. Burger, and C. Burger, “CoREST: a functional corepressor required for regulation of neural- specific gene expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 17, pp. 9873–9878, 1999. View at: Publisher Site | Google Scholar
  62. A. You, J. K. Tong, C. M. Grozinger, and S. L. Schreiber, “CoREST is an integral component of the CoREST-human histone deacetylase complex,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 4, pp. 1454–1458, 2001. View at: Publisher Site | Google Scholar
  63. R. Aasland, A. F. Stewart, and T. Gibson, “The SANT domain: a putative DNA-binding domain in the SWI-SNF and ADA complexes, the transcriptional co-repressor N-CoR and TFIIIB,” Trends in Biochemical Sciences, vol. 21, no. 3, pp. 87–88, 1996. View at: Publisher Site | Google Scholar
  64. Y.-J. Shi, C. Matson, F. Lan, S. Iwase, T. Baba, and Y. Shi, “Regulation of LSD1 histone demethylase activity by its associated factors,” Molecular Cell, vol. 19, no. 6, pp. 857–864, 2005. View at: Publisher Site | Google Scholar
  65. J. Yu, Y. Li, T. Ishizuka, M. G. Guenther, and M. A. Lazar, “A SANT motif in the SMRT corepressor interprets the histone code and promotes histone deacetylation,” EMBO Journal, vol. 22, no. 13, pp. 3403–3410, 2003. View at: Publisher Site | Google Scholar
  66. J. J. M. Cowger, Q. Zhao, M. Isovic, and J. Torchia, “Biochemical characterization of the zinc-finger protein 217 transcriptional repressor complex: identification of a ZNF217 consensus recognition sequence,” Oncogene, vol. 26, no. 23, pp. 3378–3386, 2007. View at: Publisher Site | Google Scholar
  67. Y. Shi, J.-I. Sawada, and J.-I. Sawada, “Coordinated histone modifications mediated by a CtBP co-repressor complex,” Nature, vol. 422, no. 6933, pp. 735–738, 2003. View at: Publisher Site | Google Scholar
  68. Y. Lin, Y. Wu, and Y. Wu, “The SNAG domain of snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1,” EMBO Journal, vol. 29, no. 11, pp. 1803–1816, 2010. View at: Publisher Site | Google Scholar
  69. S. Saleque, J. Kim, H. M. Rooke, and S. H. Orkin, “Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1,” Molecular Cell, vol. 27, no. 4, pp. 562–572, 2007. View at: Publisher Site | Google Scholar
  70. P. Ordentlich, M. Downes, W. Xie, A. Genin, N. B. Spinner, and R. M. Evans, “Unique forms of human and mouse nuclear receptor corepressor SMRT,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 6, pp. 2639–2644, 1999. View at: Publisher Site | Google Scholar
  71. O. Hermanson, K. Jepsen, and M. G. Rosenfeld, “N-CoR controls differentiation of neural stem cells into astrocytes,” Nature, vol. 419, no. 6910, pp. 934–939, 2002. View at: Publisher Site | Google Scholar
  72. K. Jepsen, D. Solum, and D. Solum, “SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron,” Nature, vol. 450, no. 7168, pp. 415–419, 2007. View at: Publisher Site | Google Scholar
  73. V. Perissi, K. Jepsen, C. K. Glass, and M. G. Rosenfeld, “Deconstructing repression: evolving models of co-repressor action,” Nature Reviews Genetics, vol. 11, no. 2, pp. 109–123, 2010. View at: Publisher Site | Google Scholar
  74. W. Fischle, F. Dequiedt, M. J. Hendzel, M. G. Guenther, M. A. Lazar, W. Voelter, and E. Verdin, “Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR,” Molecular Cell, vol. 9, no. 1, pp. 45–57, 2002. View at: Publisher Site | Google Scholar
  75. C. K. Glass and M. G. Rosenfeld, “The coregulator exchange in transcriptional functions of nuclear receptors,” Genes and Development, vol. 14, no. 2, pp. 121–141, 2000. View at: Google Scholar
  76. K. Jepsen, O. Hermanson, and O. Hermanson, “Combinatorial roles of the nuclear receptor corepressor in transcription and development,” Cell, vol. 102, no. 6, pp. 753–763, 2000. View at: Google Scholar
  77. H.-G. Yoon, D. W. Chan, A. B. Reynolds, J. Qin, and J. Wong, “N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso,” Molecular Cell, vol. 12, no. 3, pp. 723–734, 2003. View at: Publisher Site | Google Scholar
  78. D. Zhang, H.-G. Yoon, and J. Wong, “JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2),” Molecular and Cellular Biology, vol. 25, no. 15, pp. 6404–6414, 2005. View at: Publisher Site | Google Scholar
  79. S. S. Ng, K. L. Kavanagh, and K. L. Kavanagh, “Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity,” Nature, vol. 448, no. 7149, pp. 87–91, 2007. View at: Publisher Site | Google Scholar
  80. P. Trojer, J. Zhang, M. Yonezawa, A. Schmidt, H. Zheng, T. Jenuwein, and D. Reinberg, “Dynamic histone H1 isotype 4 methylation and demethylation by histone lysine methyltransferase G9a/KMT1C and the jumonji domain-containing JMJD2/KDM4 proteins,” Journal of Biological Chemistry, vol. 284, no. 13, pp. 8395–8405, 2009. View at: Publisher Site | Google Scholar
  81. A. Tzschach, S. Lenzner, and S. Lenzner, “Novel JARID1C/SMCX mutations in patients with X-linked mental retardation,” Human Mutation, vol. 27, no. 4, p. 389, 2006. View at: Google Scholar
  82. A. Adegbola, H. Gao, S. Sommer, and M. Browning, “A novel mutation in JARID1C/SMCX in a patient with autism spectrum disorder (ASD),” American Journal of Medical Genetics A, vol. 146, no. 4, pp. 505–511, 2008. View at: Publisher Site | Google Scholar
  83. L. R. Jensen, M. Amende, and M. Amende, “Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation,” American Journal of Human Genetics, vol. 76, no. 2, pp. 227–236, 2005. View at: Publisher Site | Google Scholar
  84. M. Tahiliani, P. Mei, and P. Mei, “The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation,” Nature, vol. 447, no. 7144, pp. 601–605, 2007. View at: Publisher Site | Google Scholar
  85. J. M. Coulson, “Transcriptional regulation: cancer, neurons and the REST,” Current Biology, vol. 15, no. 17, pp. R665–R668, 2005. View at: Publisher Site | Google Scholar
  86. J. J. Abrajano, I. A. Qureshi, S. Gokhan, D. Zheng, A. Bergman, and M. F. Mehler, “Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation,” PLoS One, vol. 4, no. 11, Article ID e7665, 2009. View at: Publisher Site | Google Scholar

Copyright © 2011 Tomohiro Hayakawa and Jun-ichi Nakayama. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles